SSA
CLPT icon

Schonfeld Strategic Advisors’s ClearPoint Neuro CLPT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-46,388
Closed -$552K – 2100
2025
Q1 		$552K Sell
46,388
-59,784
-56% -$929K ﹤0.01% 1543
2024
Q4 		$1.63M Buy
+106,172
New +$1.38M 0.01% 913
2024
Q3 		– Sell
-27,234
Closed -$147K – 2086
2024
Q2 		$147K Buy
+27,234
New +$158K ﹤0.01% 1851

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Schonfeld Strategic Advisors's CLPT Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of ClearPoint Neuro (CLPT) in Q2 2025, closing a stake of 46,388 shares — an estimated $552K sold.

Schonfeld Strategic Advisors first reported a position in CLPT in Q2 2024 and held it in 3 quarters. The position peaked at $1.63M in Q4 2024. 96 funds tracked by Wall St. Rank hold CLPT as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining ClearPoint Neuro position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 46,388 ClearPoint Neuro shares in Q2 2025, an estimated $552K.
  • Schonfeld Strategic Advisors first reported a position in ClearPoint Neuro in Q2 2024 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's ClearPoint Neuro position peaked at $1.63M in Q4 2024.
  • 96 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.